story of the week
Clinical Outcomes in Patients With De Novo Metastatic HER2-Low vs HER2-Zero Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
NPJ breast cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Clinical outcomes of de novo metastatic HER2-low breast cancer: a National Cancer Database Analysis
NPJ Breast Cancer 2022 Dec 30;8(1)135, C Jiang, S Perimbeti, L Deng, CL Shapiro, S GandhiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.